X4 Pharmaceuticals, Inc
Institutional Ownership & Holdings Analysis
About
x4-pharmaceuticals is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Bain Capital Life Sciences Investors, LLC(2025-03-31) | $4.0M |
2 | NEA Management Company, LLC(2025-03-31) | $3.5M |
3 | BlackRock, Inc.(2025-03-31) | $2.7M |
4 | VANGUARD GROUP INC(2025-03-31) | $1.9M |
5 | ACORN CAPITAL ADVISORS, LLC(2025-03-31) | $1.8M |
6 | KINGDON CAPITAL MANAGEMENT, L.L.C.(2025-03-31) | $1.7M |
7 | ORBIMED ADVISORS LLC(2025-03-31) | $1.6M |
8 | UBS Group AG(2025-03-31) | $1.2M |
9 | GSA CAPITAL PARTNERS LLP(2024-12-31) | $934.0K |
10 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $855.8K |
11 | STATE STREET CORP(2025-03-31) | $722.2K |
12 | Ensign Peak Advisors, Inc(2025-03-31) | $528.5K |
13 | Pale Fire Capital SE(2025-03-31) | $481.2K |
14 | NORTHERN TRUST CORP(2025-03-31) | $296.2K |
15 | CIBC WORLD MARKET INC.(2025-03-31) | $248.2K |
16 | AXA S.A.(2025-03-31) | $163.4K |
17 | Point72 Asset Management, L.P.(2025-03-31) | $153.7K |
18 | MORGAN STANLEY(2025-03-31) | $134.8K |
19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC(2025-03-31) | $113.8K |
20 | Knott David M Jr(2024-12-31) | $113.0K |
As of 2025-03-31
Value:$4.0M
As of 2025-03-31
Value:$3.5M
As of 2025-03-31
Value:$2.7M
As of 2025-03-31
Value:$1.9M
As of 2025-03-31
Value:$1.8M
As of 2025-03-31
Value:$1.7M
As of 2025-03-31
Value:$1.6M
As of 2025-03-31
Value:$1.2M
As of 2024-12-31
Value:$934.0K
As of 2025-03-31
Value:$855.8K
As of 2025-03-31
Value:$722.2K
As of 2025-03-31
Value:$528.5K
As of 2025-03-31
Value:$481.2K
As of 2025-03-31
Value:$296.2K
As of 2025-03-31
Value:$248.2K
#16AXA S.A.
As of 2025-03-31
Value:$163.4K
As of 2025-03-31
Value:$153.7K
As of 2025-03-31
Value:$134.8K
As of 2025-03-31
Value:$113.8K
As of 2024-12-31
Value:$113.0K
Total Institutional Holders:106
Top 10 Holders Own:82.5%